V. Mutri

Statistics

Publications

Citations

790

H-Index

Active since

2006

Affiliations

IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola(Current)

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

University of Bologna

V. Mutri is an author at IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola specializing in medicine, oncology, and chemotherapy.

Publications per year

2006–2010

Publications

Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)

Carmine Pinto, Francesca Di Fabio, Salvatore Siena et al. · Annals of Oncology · 2006 · 285 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study)

Carmine Pinto, Francesca Di Fabio, Carlo Barone et al. · British Journal of Cancer · 2009 · 142 citations · Full text

Medicine, Oncology, Pharmacology +17

Cancer Chemotherapy near the End of Life: The Time has come to set Guidelines for its Appropriate Use

Andrea Martoni, S Tanneberger, V. Mutri · Tumori Journal · 2007 · 129 citations

Medicine, Oncology, Chemotherapy +14

Does Stent Placement for Advanced Colon Cancer Increase the Risk of Perforation During Bevacizumab-Based Therapy?

Vincenzo Cennamo, Lorenzo Fuccio, V. Mutri et al. · Clinical Gastroenterology and Hepatology · 2009 · 94 citations

Medicine, Oncology, Surgery +16

The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab

Francesca Di Fabio, Carmine Pinto, Fabiola Lorena Rojas Llimpe et al. · Gastric Cancer · 2007 · 54 citations · Full text

Medicine, Oncology, Chemotherapy +13

1–5 of 9